POM-V Prescription Required

Lenzelta Suspension for Injection for Cattle

Active ingredients: Escherichia coli, Staphylococcus aureus

Form

Injection

Species

Cattle

Manufacturer

Boehringer Ingelheim Vetmedica GmbH

VMD MA No.

61700/5025

What it's used for

Onset of immunity: 4 weeks after completion of the primary vaccination course. Duration of immunity: up to 6 months after completion of the primary vaccina...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Escherichia coli + Staphyloc...

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Lenzelta Suspension for Injection for Cattle — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Onset of immunity: 4 weeks after completion of the primary vaccination course.
Duration of immunity: up to 6 months after completion of the primary vaccination
course.

Allow the vaccine to reach a temperature of 15-25 °C and shake the vial slightly before
administration. Administer one dose (2 ml) intramuscularly according to the following
schedule:
- First dose: 45 days before expected parturition date.
- Second dose: 3 weeks after the first administration.
It is recommended to administer each dose on alternate sides.
This full vaccination schedule must be repeated with each pregnancy.

None.

Cattle (cows and heifers):
Common
(1 to 10 animals / 100 animals treated):
Injection site swelling
Elevated temperature
1
swelling (up to 5 cm
) for up to 2 weeks.
a slight and transient increase in body temperature up to 1.5 °C may occur and
disappear spontaneously within the first 24 hours after the injection.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or the national competent authority via the
national reporting system. See the package leaflet for respective contact details.

The whole herd should be immunised.
Vaccination must be considered as one part of a comprehensive preventive mastitis
control programme, which should address all factors important for the mammary
gland health (e.g milking technique, drying-off and breeding management, hygiene,
nutrition, housing, bedding, cow comfort, air and water quality, health monitoring) and
other relevant management practices.
Vaccinate healthy animals only.

Special precautions for safe use in the target species:
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Seek medical advice if a local reaction occurs following accidental self-injection and
show the package leaflet to the physician.
Special precautions for the protection of the environment:
Not applicable.

No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product. A decision to use this vaccine before or after
any other veterinary medicinal product therefore needs to be made on a case-by-
case basis.

Store and transport refrigerated (2 C – 8 C).
Protect from frost.
Protect from light.

Zero days.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.